Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 09, 2024

SELL
$25.26 - $29.6 $18,945 - $22,200
-750 Reduced 8.27%
8,314 $232,000
Q1 2024

Apr 10, 2024

SELL
$25.89 - $29.73 $76,504 - $87,852
-2,955 Reduced 24.59%
9,064 $251,000
Q4 2023

Jan 11, 2024

BUY
$26.13 - $33.94 $31,408 - $40,795
1,202 Added 11.11%
12,019 $346,000
Q3 2023

Oct 13, 2023

BUY
$32.09 - $37.51 $39,727 - $46,437
1,238 Added 12.92%
10,817 $358,000
Q2 2023

Jul 13, 2023

SELL
$36.12 - $41.79 $8,343 - $9,653
-231 Reduced 2.35%
9,579 $351,000
Q1 2023

Apr 26, 2023

BUY
$39.39 - $51.28 $11,541 - $15,025
293 Added 3.08%
9,810 $400,000
Q4 2022

Jan 19, 2023

SELL
$41.75 - $54.5 $136,522 - $178,215
-3,270 Reduced 25.57%
9,517 $488,000
Q3 2022

Oct 27, 2022

SELL
$43.76 - $53.42 $386,969 - $472,393
-8,843 Reduced 40.88%
12,787 $559,000
Q2 2022

Sep 13, 2022

SELL
$46.53 - $55.17 $1.02 Million - $1.21 Million
-21,951 Reduced 50.37%
21,630 $1.13 Million
Q1 2022

Sep 13, 2022

SELL
$45.75 - $56.69 $89,944 - $111,452
-1,966 Reduced 4.32%
43,581 $2.26 Million
Q4 2021

Sep 13, 2022

SELL
$41.32 - $61.25 $46,154 - $68,416
-1,117 Reduced 2.39%
45,547 $2.69 Million
Q3 2021

Sep 12, 2022

SELL
$39.25 - $50.42 $161,396 - $207,327
-4,112 Reduced 8.1%
46,664 $2.01 Million
Q2 2021

Sep 10, 2021

SELL
$35.91 - $40.68 $29,015 - $32,869
-808 Reduced 1.57%
50,776 $1.99 Million
Q1 2021

Sep 13, 2021

SELL
$33.49 - $37.77 $84,495 - $95,293
-2,523 Reduced 4.66%
51,584 $1.87 Million
Q4 2020

Sep 20, 2021

BUY
$33.47 - $42.56 $1.53 Million - $1.94 Million
45,667 Added 541.08%
54,107 $1.99 Million
Q3 2020

Oct 21, 2020

SELL
$31.75 - $37.25 $13,811 - $16,203
-435 Reduced 4.9%
8,440 $309,000
Q2 2020

Jul 21, 2020

BUY
$30.12 - $36.54 $267,315 - $324,292
8,875 New
8,875 $290,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $147B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Sunflower Bank, N.A. Portfolio

Follow Sunflower Bank, N.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sunflower Bank, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Sunflower Bank, N.A. with notifications on news.